Deepa Lalla
Advertisement
Articles by Deepa Lalla
Advertisement
Latest Updated Articles
24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)Published: April 18th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Report Finds Seventy Percent 5-Year Survival Rate for All Cancers Combined
2
FDA Grants Breakthrough Therapy Designation to ICT01 in Frontline AML
3
Optimizing Cellular Therapy Use Across All Stages of Multiple Myeloma
4
Phase 1 Study Evaluating JNJ-80038114 in Metastatic CRPC Discontinues Early
5